BCS Wealth Management bought a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 12,781 shares of the company's stock, valued at approximately $1,162,000.
Several other institutional investors also recently modified their holdings of CL. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the third quarter worth $53,000. Prospera Private Wealth LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at $64,000. True Wealth Design LLC lifted its holdings in Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC grew its position in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock valued at $79,000 after buying an additional 368 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the company. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Finally, Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $103.63.
View Our Latest Report on CL
Colgate-Palmolive Stock Up 0.7 %
Shares of CL traded up $0.63 on Tuesday, reaching $87.73. The company's stock had a trading volume of 4,606,624 shares, compared to its average volume of 5,109,228. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30. The stock has a market capitalization of $71.68 billion, a PE ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm has a fifty day moving average of $92.36 and a 200-day moving average of $97.92.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.
Insider Activity
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.34% of the company's stock.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
